Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Helen E. BryantThe Institute for Cancer Studies, University of Sheffield, Medical School, Beech Hill Road, Sheffield S10 2RX, UKNiklas SchultzDepartment of Genetics, Microbiology and Toxicology, Arrhenius Laboratory, Stockholm University, S-106 91, Stockholm, SwedenHuw D. ThomasNorthern Institute for Cancer Research, University of Newcastle upon Tyne, Medical School, NE2 4HH, Newcastle upon Tyne, UKKayan M. ParkerThe Institute for Cancer Studies, University of Sheffield, Medical School, Beech Hill Road, S10 2RX, Sheffield, UKDan FlowerThe Institute for Cancer Studies, University of Sheffield, Medical School, Beech Hill Road, S10 2RX, Sheffield, UKElena López‐KnowlesThe Institute for Cancer Studies, University of Sheffield, Medical School, Beech Hill Road, S10 2RX, Sheffield, UKSuzanne KyleNorthern Institute for Cancer Research, University of Newcastle upon Tyne, Medical School, NE2 4HH, Newcastle upon Tyne, UKMark MeuthThe Institute for Cancer Studies, University of Sheffield, Medical School, Beech Hill Road, S10 2RX, Sheffield, UKNicola J. CurtinNorthern Institute for Cancer Research, University of Newcastle upon Tyne, Medical School, NE2 4HH, Newcastle upon Tyne, UKThomas HelledayDepartment of Genetics, Microbiology and Toxicology, Arrhenius Laboratory, Stockholm University, S-106 91, Stockholm, Sweden
2005en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0